Posted by SLS on March 17, 2010, at 23:49:45
In reply to Re: My letter to the FDA » Bob, posted by floatingbridge on March 16, 2010, at 0:21:40
The SSRI discontinuation syndrome is no longer completely ignored. Studies are being designed to explore the phenomenon more closely. Recently, a study of SSRI discontinuation syndrome using paroxetine and fMRI demonstrated a set of functional differences in brain activity during symptomatic episodes. The syndrome is now recognized by science, although it may not be by all clinical practitioners. Drug companies know about this stuff. I imagine they would rather not call any attention to it. Hopefully, letters to the FDA will not fall upon deaf ears. I just hope that the populace does not use the existence of this discontinuation syndrome to further fuel the backlash against antidepressants in general. We still need these drugs.
- Scott
poster:SLS
thread:939283
URL: http://www.dr-bob.org/babble/20100305/msgs/939883.html